scholarly article | Q13442814 |
P2093 | author name string | Eckersberger F | |
Valent P | |||
Lechner K | |||
Bettelheim P | |||
Ashman LK | |||
Majdic O | |||
Hinterberger W | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mast cell | Q191989 |
P304 | page(s) | 1778-1785 | |
P577 | publication date | 1989-05-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes | |
P478 | volume | 73 |
Q35840749 | Aberrant splicing of the hRasGRP4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis |
Q41387536 | Adhesion molecules on the human mast cell line HMC-1 are upregulated during cell activation |
Q38711198 | BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils |
Q37348437 | Basic and clinical immunology of Siglecs |
Q71173482 | Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes |
Q37801973 | Cytokine-induced human basophil/mast cell growth and differentiation in vitro |
Q34326480 | Development of human mast cells in vitro |
Q45081017 | Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. |
Q41614610 | Differential expression of cell surface integrins on human mast cells and human basophils |
Q71699648 | Differential response of human basophils and mast cells to recombinant chemokines |
Q42803560 | Direct transplantation of chronic myelogenous leukemia cells into nude mice and establishment of a leukemic stem cell (Ph1+, CD34+) line dependent on mouse bone marrow stromal cells in vitro |
Q36330511 | Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells |
Q42803669 | Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. |
Q45977986 | Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation. |
Q39689493 | H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells |
Q35848531 | Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor |
Q42045097 | Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis |
Q99409940 | In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells |
Q34291889 | Interleukin 3 activates human blood basophils via high-affinity binding sites. |
Q37484203 | Interleukin 4 promotes expression of mast cell ICAM-1 antigen |
Q99419174 | Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts |
Q39348704 | NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation. |
Q33565482 | Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate |
Q41558181 | PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule |
Q41552020 | Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells |
Q41506649 | Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells |
Q39606792 | Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536. |
Q60046861 | Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs |
Q36016817 | Ras guanine nucleotide-releasing protein-4 (RasGRP4) involvement in experimental arthritis and colitis |
Q28828739 | Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth |
Q28480417 | The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils |
Q39651618 | Use of monoclonal antibody KP1 for identifying normal and neoplastic human mast cells |
Search more.